Projekte unter der Sponsorschaft der AIO-Studien-gGmbH

Mammakarzinom

AIO-MAM-0110: Randomized phase II study to compare Vinorelbine In combination with the mTOR Inhibitor
Everolimus vs. Vinorelbin monotherapy for second-line treatment in advanced breast (VicTORia)
cancer